Gennova Biopharmaceuticals Gets Nod For Human Trial Of Its Covid Vaccine

The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova...

from NDTV News - Latest https://ift.tt/3n5axcH
via IFTTT

Advertisement